Outlook Therapeutics
OTLK
#8583
Rank
C$0.16 B
Marketcap
$7.17
Share price
-2.84%
Change (1 day)
-39.18%
Change (1 year)

Earnings for Outlook Therapeutics (OTLK)

Earnings in 2024 (TTM): -C$0.13 Billion

According to Outlook Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$71.94 Million, an increase over its 2022 earnings that were of -C$98.14 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Outlook Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.13 Billion75.75%
2023 -C$71.94 Million-26.7%
2022 -C$98.14 Million32.13%
2021 -C$74.28 Million46.21%
2020 -C$50.81 Million-18.82%
2019 -C$62.58 Million16.62%
2018 -C$53.66 Million57.88%
2017 -C$33.99 Million-56.17%
2016 -C$77.55 Million-9.26%
2015 -C$85.46 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.16 Billion 21.71% Jersey
-C$0.39 Billion 190.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$19.54 Million-85.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.11 Billion-22.31%๐Ÿ‡ฌ๐Ÿ‡ง UK